BioGaia AB

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: SE0017769995

SEK

118.80

-0.9 (-0.75%)

Jun 26

OME

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Midsona AB

Lohilo Foods AB

New Nordic Healthbrands AB

BioGaia AB

Wntresearch AB

Veg of Lund AB

DanCann Pharma A/S

Nicoccino Holding AB

Eevia Health Plc

Hemply Balance Holding AB

Why is BioGaia AB ?

Flat results in Mar 26

OPERATING CASH FLOW(Y) Lowest at SEK 341.2 MM
CASH AND EQV(HY) Lowest at SEK 1,673.09 MM
OPERATING PROFIT MARGIN(Q) Lowest at 27.24 %

With ROE of 25.32%, it has a very attractive valuation with a 8.98 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 22.64%, its profits have fallen by -5.3%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is BioGaia AB for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

BioGaia AB

20.12%

6.66

28.83%

OMX Stockholm 30

28.68%

1.89

15.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.54%

EBIT Growth (5y)

13.08%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.70

Sales to Capital Employed (avg)

0.88

Tax Ratio

21.81%

Dividend Payout Ratio

49.86%

Pledged Shares

Institutional Holding

ROCE (avg)

77.27%

ROE (avg)

15.46%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

8.98

EV to EBIT

24.34

EV to EBITDA

23.08

EV to Capital Employed

21.45

EV to Sales

7.15

PEG Ratio

Dividend Yield

28.43%

ROCE (Latest)

88.12%

ROE (Latest)

25.32%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

-5What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at SEK 341.2 MM

CASH AND EQV(HY)

Lowest at SEK 1,673.09 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 27.24 %

Here's what is not working for BioGaia AB

Operating Cash Flow

Lowest at SEK 341.2 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (SEK MM)

Operating Profit Margin

Lowest at 27.24 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Cash and Eqv

Lowest at SEK 1,673.09 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents